Prurigo Nodularis
Symptoms, Doctors, Treatments, Advances & More

Prurigo Nodularis Overview

Save information for later
Sign Up

Learn About Prurigo Nodularis

What is the definition of Prurigo Nodularis?
Prurigo nodularis (PN) is a skin disease that causes hard, itchy lumps (nodules) to form on the skin. The itching (pruritus) can be intense, causing people to scratch themselves to the point of bleeding or pain. Scratching can cause more skin lesions to appear. In some cases, people with PN have a history of other diseases including eczema (atopic dermatitis), lymphoma, HIV infection, severe anemia, or kidney disease. The exact cause of PN is unknown. Although scratching is known to cause more nodules to appear, it is unclear what causes the itching to develop in the first place. Diagnosis of the disease is based on observing signs such as extremely itchy skin with the formation of nodules. In some cases, a skin biopsy is used to confirm the diagnosis.
What are the alternative names for Prurigo Nodularis?
  • Prurigo nodularis
  • Nodular prurigo
Who are the top Prurigo Nodularis Local Doctors?
Elite in Prurigo Nodularis
Dr. Nishadh Sutaria
Dermatology
Elite in Prurigo Nodularis
Dr. Nishadh Sutaria
Dermatology

Olive View-UCLA Medical Center

14445 Olive View Dr, 
Sylmar, CA 
747-210-3064
Languages Spoken:
English

Nishadh Sutaria is a Dermatologist practicing medicine in Sylmar, California. Dr. Sutaria is rated as an Elite provider by MediFind in the treatment of Prurigo Nodularis. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Prurigo Nodularis, Lichen Simplex Chronicus, Atopic Dermatitis, Mycosis Fungoides, and Transcatheter Aortic Valve Replacement (TAVR).

Elite in Prurigo Nodularis
Dr. Joseph Zahn
Dermatology
Elite in Prurigo Nodularis
Dr. Joseph Zahn
Dermatology

GW The Medical Faculty Associate

2150 Pennsylvania Ave NW, 
Washington, DC 
202-741-2600
Languages Spoken:
English
See accepted insurances

Joseph Zahn is a Dermatologist practicing medicine in Washington, Washington, D.c.. Dr. Zahn is rated as an Elite provider by MediFind in the treatment of Prurigo Nodularis. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Prurigo Nodularis, Squamous Cell Skin Carcinoma, Atopic Dermatitis, and Bowen's Disease.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Prurigo Nodularis
Dr. Shawn Kwatra
Dermatology
Elite in Prurigo Nodularis
Dr. Shawn Kwatra
Dermatology
100 Brown St Fl 3, 
Chestertown, MD 
667-214-1171
Languages Spoken:
English
See accepted insurances

Shawn Kwatra is a Dermatologist practicing medicine in Chestertown, Maryland. Dr. Kwatra is rated as an Elite provider by MediFind in the treatment of Prurigo Nodularis. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Prurigo Nodularis, Atopic Dermatitis, Lichen Simplex Chronicus, and Actinic Keratosis.

View All Doctors
What are the latest Prurigo Nodularis Clinical Trials?
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis
Enrollment Status: Recruiting
Publish Date: April 13, 2026
Intervention Type: Drug
Study Phase: Phase 3

Summary: The purpose of this study is to evaluate effect of povorcitinib on itch and skin lesions in participants with prurigo nodularis.

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of the Efficacy and Safety of ICP-332 in Participants With Prurigo Nodularis
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of the Efficacy and Safety of ICP-332 in Participants With Prurigo Nodularis
Enrollment Status: Recruiting
Publish Date: April 09, 2026
Intervention Type: Drug
Study Phase: Phase 2

Summary: Evaluate the efficacy and safety of ICP-332 in participants with Prurigo Nodularis (PN)

View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center